Ecolab Inc. (BIT:1ECL)

Market Cap	67.21B
Revenue (ttm)	13.39B
Net Income (ttm)	1.82B
Shares Out	n/a
EPS (ttm)	6.37
PE Ratio	36.95
Forward PE	34.71
Dividend	2.29 (0.99%)
Ex-Dividend Date	Jun 16, 2025

Volume	n/a
Average Volume	5
Open	231.00
Previous Close	231.00
Day's Range	231.00 - 231.00
52-Week Range	196.40 - 258.50
Beta	n/a
RSI	54.86
Earnings Date	Jul 29, 2025

About Ligand Pharmaceuticals

Ecolab Inc. provides water, hygiene, and infection prevention solutions and services in the United States and internationally. The company operates through four reportable segments: Global Industrial, Global Institutional & Specialty, Global Healthcare & Life Sciences, and Global Pest Elimination. The Global Industrial segment offers water treatment and process applications, and cleaning and sanitizing solutions to manufacturing, food and beverage processing, transportation, chemical, metals and mining, power generation, refining, pulp and pape...

• Industry: Specialty Cleaning, Polishing, and Sanitation Preparations
• Founded: 1923
• Employees: 48,000
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1ECL

Financial Performance

In 2024, Ecolab's revenue was $15.74 billion, an increase of 2.75% compared to the previous year's $15.32 billion. Earnings were $2.11 billion, an increase of 53.93%.